[1]
Nurachman, A. 2025. PHARMACOVIGILANCE AND OFF-GUIDELINE USE FOR GABAPENTIN IN FIBROMYALGIA: A REVIEW OF SAFETY PROFILES AND PRESCRIBING PATTERNS. Journal of Research in Pharmacy and Pharmaceutical Sciences. 4, 1 (Jun. 2025), 31–42. DOI:https://doi.org/10.33533/jrpps.v4i1.11312.